See All Slides - tctmd.com

Slides

Presentation AHA 2012

The TIME Randomized Trial: Effect of Intracoronary Delivery of Autologous Bone Marrow Mononuclear on Timing of Delivery following AMI on Left Ventricular Function

Presenter: Jay H. Traverse

November 05, 2012

Presentation AHA 2012

Results of Exenatide Myocardial Protection In REvascularization (EMPIRE) Study

Presenter: Weon Kim

November 04, 2012

Presentation AHA 2012

Rivaroxaban Use is Associated with Reduced Risk of Myocardial Infarction- Insights from a Meta-analysis and Trial Sequential Analysis of Randomized Clinical Trials

Presenter: Saurav Chatterjee

November 04, 2012

Presentation AHA 2012

FREEDOM Trial Main Results

Presenter: Valentin Fuster

November 04, 2012

Presentation AHA 2012

Economic Outcomes of Percutaneous Coronary Intervention Performed at Sites With and Without On-Site Cardiac Surgery

Presenter: Eric L. Eisenstein

November 04, 2012

Presentation AHA 2012

First Large-Scale Platelet Function Evaluation in an Acute Coronary Syndromes Trial: The TRILOGY ACS — Platelet Function Substudy

Presenter: Paul A. Gurbel

November 04, 2012

Presentation TCT 2012

Introduction to the TAVR Procedure

Presenter: Martyn Thomas

October 26, 2012

Presentation TCT 2012

Developing an Efficient and Effective TAVR Patient Screening Process: Outreach Programs, Valve Clinics, Screening Workups, and Case Scheduling

Presenter: Bruce Bowers

October 26, 2012

Presentation TCT 2012

Case 2: Alternative (Nonfemoral) Vascular Access

Presenter: Nicolas van Mieghem

October 26, 2012

Presentation TCT 2012

Creating the Optimal TAVR Procedural Venue: Hybrid Cath Lab/ORs, Staffing, Stocking, and Other Logistics

Presenter: Alan Lumsden

October 26, 2012

Advertisement

Slides

The TIME Randomized Trial: Effect of Intracoronary Delivery of Autologous Bone Marrow Mononuclear on Timing of Delivery following AMI on Left Ventricular Function

Results of Exenatide Myocardial Protection In REvascularization (EMPIRE) Study

Rivaroxaban Use is Associated with Reduced Risk of Myocardial Infarction- Insights from a Meta-analysis and Trial Sequential Analysis of Randomized Clinical Trials

FREEDOM Trial Main Results

Economic Outcomes of Percutaneous Coronary Intervention Performed at Sites With and Without On-Site Cardiac Surgery

First Large-Scale Platelet Function Evaluation in an Acute Coronary Syndromes Trial: The TRILOGY ACS — Platelet Function Substudy

Introduction to the TAVR Procedure

Developing an Efficient and Effective TAVR Patient Screening Process: Outreach Programs, Valve Clinics, Screening Workups, and Case Scheduling

Case 2: Alternative (Nonfemoral) Vascular Access

Creating the Optimal TAVR Procedural Venue: Hybrid Cath Lab/ORs, Staffing, Stocking, and Other Logistics

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content